Irritable Bowel Syndrome (IBS) is a chronic condition that affects the functioning of the digestive system, especially the ...
("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, ...
Brian Carrico, President and Chief Executive Officer of NeurAxis commented, “We are thrilled about our coverage with Molina, which marks our initial expansion into the states of MI, IL, NY, TX, and ...
Irritable Bowel Syndrome (IBS) affects 10-15% of Americans. Dietary changes, like increasing fiber or following a low FODMAP diet, help manage symptoms. Avoiding trigger foods and staying hydrated is ...
HealthDay News — For patients with type 1 diabetes with moderate-to-severe gastrointestinal symptoms, fecal microbiota transplantation (FMT) is safe and improves clinical outcomes, according to a ...